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Modelling of psychosocial and 
lifestyle predictors of peripartum 
depressive symptoms associated 
with distinct risk trajectories: a 
prospective cohort study
Sarah English1, Amber Steele2, Alison Williams3, Jayne Blacklay3, Olanrewaju Sorinola1,3, 
Lorenz Wernisch2 & Dimitris K. Grammatopoulos1,4
Perinatal depression involves interplay between individual chronic and acute disease burdens, biological 
and psychosocial environmental and behavioural factors. Here we explored the predictive potential of 
specific psycho-socio-demographic characteristics for antenatal and postpartum depression symptoms 
and contribution to severity scores on the Edinburgh Postnatal Depression Scale (EPDS) screening 
tool. We determined depression risk trajectories in 480 women that prospectively completed the EPDS 
during pregnancy (TP1) and postpartum (TP2). Multinomial logistic and penalised linear regression 
investigated covariates associated with increased antenatal and postpartum EPDS scores contributing 
to the average or the difference of paired scores across time points. History of anxiety was identified as 
the strongest contribution to antenatal EPDS scores followed by the social status, whereas a history of 
depression, postpartum depression (PPD) and family history of PPD exhibited the strongest association 
with postpartum EPDS. These covariates were the strongest differentiating factors that increased 
the spread between antenatal and postpartum EPDS scores. Available covariates appeared better 
suited to predict EPDS scores antenatally than postpartum. As women move from the antenatal to the 
postpartum period, socio-demographic and lifestyle risk factors appear to play a smaller role in risk, and 
a personal and family history of depression and PPD become increasingly important.
Depression during pregnancy, around childbirth or within the first year postpartum, collectively termed as 
perinatal depression (PND), is now recognised as a major health burden both for the mother, her family and 
the offspring1,2. Across most ethnic groups perinatal depression is experienced by 10–20% of women3,4 exhib-
iting similar prevalence to depression in the general population. It is now considered one of the most common 
non-obstetric complications associated with childbearing.
Similar to general depression, PND is a heterogeneous complex disorder that involves bidirectional interplay 
of stress vulnerability, depression and health outcomes5. Individual chronic/acute burdens associated with previ-
ous history of illness that precipitate or exacerbate depressive symptoms play a major role in stress vulnerability 
as well as factors relevant to biological and psychosocial environment such as demographics and socioeconomic 
status, social support and lifestyle6,7. Major meta-analysis studies identified a number of key predictors of post-
partum depression (PPD) including history of depression, antenatal depression and anxiety, major stressful life 
events, social support levels, low self-esteem and income and negative cognitive attributional style3,8,9. History of 
depression, antenatal anxiety, low self-esteem, social support, income and educational attainment are also predis-
posing factors for antenatal depression (AND)10–13.
Routine screening is strongly encouraged by the American College of Obstetricians and Gynecologists 
(ACOG) Committee on Obstetric Practice in the US, US Preventive Services Task Force and the National 
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Collaborating Centre for Mental Health in the UK14–16. The Edinburgh Postnatal Depression Scale (EPDS) is the 
most commonly used standardized screening tool for both antenatal (AND) and postpartum (PPD) depressive 
symptoms and is recommended by the National Institute of Clinical Excellence16. Although there is no consensus 
agreement on the most appropriate cut-off, for screening purposes a cut-off score of 10 is widely cited to indicate 
possible major or minor depressive disorder17,18, whereas the cutoff of 13 is typically used for identifying major 
depressive disorder (MDD)15.
Studies sampling EPDS scores at different time points during pregnancy and postpartum report considerable 
variability in the pattern of symptom onset, recurrence and duration, and severity19; for example although most 
studies agree that antenatal depressive symptoms are generally associated with PPD, not all women with PPD 
report raised EPDS during pregnancy. In fact, studies including our own pilot19–22 suggest that women exhibit 
diverse, either ascending or descending trajectories in EPDS scores during pregnancy and postpartum. Whether 
specific risk factors determine or influence the direction of EPDS score trajectories is poorly understood, and very 
few studies have addressed this. Thus, identifying key psychosocial, lifestyle and pregnancy covariates as predic-
tors of changes between antenatal and postpartum EPDS scores might be important and improve EPDS predictive 
accuracy and potential use in a screening protocol.
By recording antenatal and postpartum EPDS scores together with profiling psychosocial, lifestyle and preg-
nancy related information, routinely gathered during antenatal hospital visits, in this prospective study we ini-
tially investigated whether distinct patterns of onset and persistence of PND symptoms from pregnancy to the 
postpartum period are associated with different risk profiles. This analysis was based on modeling by discretiza-
tion applying well-established cutoffs. In addition, data analysis using a full undiscretized EPDS scale, explored 
the usefulness of covariates as predictors of either antenatal or postpartum EPDS scores in order to identify covar-
iates that can support a “predictive” model capable of forecasting raised EPDS scores. A second aim of the analysis 
was to detect whether systematic differences between antenatal and postpartum EPDS scores exist, potentially 
hinting at different aetiologies.
Results
Antenatal-postpartum EPDS score distributions and predictive performance. The complete data 
set consisted of 480 matched pairs with completed antenatal and postpartum EPDS scores. Distribution and 
frequencies of EPDS scores are displayed in Suppl. Fig. 1a [studies comparing the antenatal (T1) and postpartum 
(T2) EPDS scores are also shown in the Penalised Regression analysis and prediction section]. A detailed descrip-
tion of the cohort EPDS score characteristics is presented in the Supplementary Results. Using the cut-off of 10 
to categorize EPDS scores as ‘high’ or ‘low’ risk, the risk trajectory defined by EPDS scores during pregnancy and 
postpartum period determined classification of participants into four groups for the initial analysis (Table 1). 
Group 0 represents a low risk trajectory, Group 3 an overall high-risk trajectory, and Groups 1 & 2 transient risk 
trajectories with either an increase (group 1) or decrease (group 2) in postpartum EPDS scores.
Previous studies also investigated predictive accuracy of the antenatal EPDS for postpartum EPDS at different 
cut-offs21. For a comparison with these studies we established how far an antenatal EPDS score ≥10 during the 
3rd trimester could directly predict an EPDS score ≥10 6–10 w postpartum (Table 2). To assess the predictive 
power under a range of all possible cut-offs we measured the area under the ROC curve obtaining a value of 0.76 
shown in Fig. 1, which confirms previous studies21. Further details on predictive performance of the antenatal and 
postpartum EPDS score are shown in Table 2. These results are essentially identical to previous studies21 albeit 
requiring a slight shift in the EPDS cut-off to obtain similar levels of NPV and PPV.
Multinomial logistic regression – group analysis. To investigate whether distinct patterns of onset and 
persistence of PND symptoms from pregnancy to the postpartum period are associated with different risk pro-
files, we dichotomised EPDS scores using standard cut-offs to define a binary outcome of depressive risk status. 
This approach is relevant to clinical guidelines and routine healthcare practice of risk assessment and provides a 
Group Total N %
0 - Overall Low Depressive Risk 379 79.0
1 - Low antenatal risk, High risk postpartum 46 9.6
2 - High antenatal risk, Low risk postpartum 30 6.3
3 - Overall High Depressive Risk 25 5.2
Table 1. Distribution of the cohort within created Group variables.
Cut-off ≥15 Cut-off ≥10 Cut-off ≥5
Sensitivity % (95% CI) 16.3 (3.9) 39.1 (5.1) 79.3 (4.2)
Specificity % (95% CI) 99.0 (0.5) 90.8 (1.5) 56.5 (2.5)
PPV % (95% CI) 78.9 (9.4) 50.7 (5.9) 30.5 (3.0)
NPV % (95% CI) 83.1 (1.8) 86.1 (1.7) 91.9 (1.8)
Table 2. Predictive performance of antenatal EPDS score at various cut-offs for a postpartum EPDS score ≥10 
(standard error in brackets). The area under the ROC curve for all cut-offs (see Fig. 3) is 0.756.
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means of elucidating the heterogeneity of symptoms severity across women. In this way we obtained estimates of 
effects and their significance that are more robust to potential misspecifications of the regression models. Initial 
bivariate chi-squared analysis identified 11 potential correlates associated with antenatal/postpartum depressive 
symptoms, which were further analysed. Complete results are shown in Suppl. Tables 3 and 4. All risk factors with 
a p < 0.05, either pre- or post-delivery, were included in a multinomial regression model for the group analysis. 
The overall p-value for this model was 0.0002. The low risk (EPDS <10) group was used as a baseline category. 
Relative risk values (RR) were calculated to give a better understanding of the magnitude of association between 
covariates as risk factors and the 3 groups with distinct risk trajectories (Table 3).
For group 1 (T2 EPDS ≥10 only), significant risk factors were found to be ‘Past history of PPD’ and ‘Past 
history of depression’. In group 2 (T1 EPDS ≥10 only), risk factors were a ‘Past history of anxiety’, Age (<25)’ 
and ‘Ethnicity (minority)’, although it is important to note that 84.6% of the cohort were White British. An age of 
40+ also increased the risk of being in Group 2 (RR = 4.17) but this association was not quite significant and was 
relevant to <10% of the cohort. In group 3 (both T1 and T2 EPDS ≥10), ‘Past history of depression’ was the only 
significant risk factor.
Penalised Regression analysis and prediction. In the previous section we identified covariates which 
constitute major risk factors for either group 1 (history of PPD, history of depression), group 2 (history of anxiety, 
ethnicity, age), or group 3 (history of depression). It is likely that dichotomising EPDS scores results in loss of 
statistical power; it also depends on specific cut-off values. We therefore repeated the regression analysis on the 
full range of EPDS scores without dichotomisation. The relationship between the antenatal (T1) and postpartum 
(T2) EPDS scores, with a correlation of 0.5002, is shown in Fig. 2. The deviance from perfect correlation and 
alignment can be attributed to any systematic change (drop or increase) in depressive symptoms from before to 
after delivery, but also to unexplained variability (noise) in the acquisition of EPDS scores.
In the following section we present linear as well as nonlinear regression analyses for the antenatal and post-
partum EPDS scores, for the difference between them and finally for their average. The purpose of these four 
analyses is to explore whether covariates contributing to a high antenatal score are different from covariates con-
tributing to a high postpartum score (compare also with Fig. 1) and which covariates contribute to both. Details of 
the regression analysis can be found in the methods section and the supplementary material.
Antenatal EPDS score. Variables contributing to a linear model for antenatal EPDS scores were selected 
using penalised regression. Once variables were selected, regression were calculated by standard linear regression. 
Coefficients with a p < 0.05 are shown in Table 4 (the full model is listed in Suppl. Table 5).
Covariates that appeared particularly important in the prediction of antenatal EPDS scores were ‘past history 
of anxiety’ contributing around 2 points toward the EPDS score, the most significant contribution in terms of a 
p-value, with further contributions identified from ‘social status as Unemployed/student’, contributing almost 4 
points towards the antenatal EPDS score, and ‘Semi-routine/routine/HW work’ contributing about 1.8 points. 
Other significant contributions come from a ‘family history of PPD’ as well as ‘alcohol consumption’. Marginal 
protective effects were identified from ‘education beyond 18 years’ and a higher BMI. Although not significant, 
further variables contributed to increased prediction accuracy as listed in Suppl. Table 3.
We also fitted a model adding all pairwise interactions. However, the cross validated mean squared prediction 
error was unchanged indicating that adding interactions does not improve predictive power and we therefore did 
not further consider such models or any models with higher orders of interaction.
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Figure 1. ROC curve (convex hull) for prediction of postpartum EPDS score ≥10 from antenatal EPDS scores 
(AROC 0.756) at various cut-offs (crosses).
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Postpartum EPDS scores. As above a linear model for postpartum EPDS scores was selected using penal-
ised regression. Coefficients with a p < 0.05 are shown in Table 5 (for a full list see Suppl. Table 6). Fewer covari-
ates identified as significant compared to the antenatal EPDS score model. ‘Past history of depression’, ‘Past history 
as well as a family history of PPD,’ contributed about 2.8, 2.2, and 1.8 points to the postpartum EPDS, respectively. 
Information about pre-existing illness and associated medication as well as level of education improved predic-
tion accuracy although their effect was not statistically significant.
Differences and commonalities between antenatal and postpartum EPDS scores. We explored 
systematic differences between antenatal and postpartum EPDS scores in terms of potentially different sets of 
covariates, and covariates that would explain the drop or rise in antenatal to postpartum EPDS scores observed 
in many subjects. Therefore, we investigated within-person patterns of change by analysing the contribution 
of covariates to the differences and averages of postpartum (T2) and antenatal (T1) EPDS scores. The ‘average’ 
EDPS score [APA score = (T1 + T2)/2] can be seen as an indication of overall perinatal depression not specific 
to either an antenatal or postpartum time point; identified covariates contributing to the average score would 
indicate common underlying factors. The ‘difference’ in EPDS scores [DPA score = (T1 − T2)] corresponds to the 
improvement or worsening in EPDS score from the antenatal to the postpartum time point; covariates contribut-
ing to the difference of T1 to T2 score, would indicate differentiating factors. The relationship between difference 
and average score is illustrated in Fig. 3. The two components are also indicated as average and difference axes in 
Fig. 2. Their correlation with different sets of predictors is discussed below.
Difference between postpartum and antenatal EPDS scores. We analysed covariates, which contribute to the DPA 
score in order to find correlates explaining why some individuals exhibited a drop in score from before to after 
delivery while others showed the opposite effect. Table 6 shows significant coefficients of a linear model selected 
by penalised regression (the full model is shown in Suppl. Table 7). Negative coefficients indicate a decrease from 
antenatal to postpartum EPDS score, while positive coefficients indicate an increase. The clinical significance of a 
1 point change in EPDS score represents a “small change”, 2–3 points a “medium change” and 4 points or higher 
a “large change”23.
Based on our regression analysis one would expect covariates that contribute to T1 EPDS score (Table 4) but 
not T2 EPDS score (Table 5) to exert negative coefficients in this analysis, since they can explain antenatal but not 
postpartum depressive symptoms. Conversely covariates that show up in Table 5 but not Table 4 are expected to 
have positive coefficients in the difference analysis, since these covariates are associated with postpartum but not 
antenatal depressive symptoms. This was confirmed in our analysis: two differentiating factors between antenatal 
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Figure 2. Antenatal vs postpartum EPDS scores for 474 individuals (correlation 0.5002). Points are jittered 
randomly for better visibility. Sections of the graph represent groups created in the previous analysis.
Group Risk factors
1 – High postpartum risk Past history of PPD (p = 0.017, RR = 3.78)Past history of depression (p = 0.034, RR = 2.76)
2 – High antenatal risk
Past history of anxiety (p = 0.013, RR = 3.55)
Ethnicity - minority (p = 0.006, RR = 5.19)
Age - <24 (p = 0.010, RR = 6.39)
3 – Overall high risk Past history of depression (p = 0.045, RR = 3.51)
Table 3. Relative Risk (RR) values for significant variables within each at risk group.
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Figure 3. (a) A schematic of the relationship between contribution of covariates identified by a linear model to 
the differences and averages of postpartum and antenatal EPDS scores. The ‘average’ EDPS score at T1 and T2 time 
points (APA score) can be seen as an indication of overall perinatal depression not specific to either an antenatal or 
postpartum time point. The ‘difference’ in EPDS scores (DPA score) corresponds to shifts in EPDS score from the 
antenatal to the postpartum time point indicative of improvement or worsening. (b) Representative case studies 
of cohort patients with covariates that shift DPA and APA scores. Subject #5 who had two covariates with negative 
coefficients, a ‘previous history of anxiety’ and a ‘social status of student/unemployed’, exhibited a significant drop 
in the DPA score. Subject #482 had a covariate with positive coefficient, a ‘previous history of depression’ and 
exhibited an increase in the DPA score. In this patient, the covariates ‘past history of PPD’ as well as ‘past history 
of depression’ might contribute to the APA score. Subject #196 had covariates with both negative and positive 
coefficients, a previous history of anxiety’ and ‘previous history of depression’ and exhibited a small increase in the 
DPA score. In this patient, the APA score was also influenced by at least 3 covariates with positive coefficients, such 
as ‘family history of PPD’, ‘past history of depression’ and ‘social status’.
Covariate Coefficient p-value
Social status - Routine/semi-routine/HW 1.768 <0.001
Social status - Unemployed/student 3.887 0.004
Education >18 years −1.373 0.033
BMI ≥30 - Yes −0.581 0.037
Alcohol pre-pregnancy - Yes 0.813 0.049
Family history of PPD, 1st degree relative - Yes 1.391 0.012
Past history of anxiety - Yes 2.314 <0.001
Table 4. Significant covariates of a linear model for antenatal EPDS scores. Positive or negative coefficients 
indicate by how much the EDPS score increases or decreases with the covariate. The full model is provided in 
Suppl. Table 5.
Covariate Coefficient p-value
Past history of PPD - Yes 2.204 0.014
Past history of depression - Yes 2.788 <0.001
Family history of PPD - 1st degree relative - Yes 1.779 0.003
Table 5. Significant covariates of a linear model for postpartum EPDS scores. The full model is provided in 
Suppl. Table 6.
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and postpartum scores were a ‘past history of anxiety’ or a ‘social status of student/unemployed’. In the current 
analysis they were both associated with a drop in the EPDS score by over 2 points from before to after delivery. 
The reverse was also observed, and a ‘past history of depression’, which was significant for postpartum EPDS score 
only (Table 6) contributed to an increase in the EPDS score by about 2 points.
Average of postpartum and antenatal EPDS scores. Significant covariates, which contribute to the average of 
postpartum and antenatal EPDS scores indicate subject characteristics underlying both scores and are shown in 
Table 7 (the full model is listed in Suppl. Table 8). As expected, a ‘past history of PPD’ as well as ‘past history of 
depression’ and ‘a family history of PPD’ contribute to a higher average EPDS score. In contrast, a ‘longer gestation’ 
is associated with a reduction in score. Slightly surprising, obesity might contribute marginally to a reduction in 
score, but the overall effect was weak. These findings are presented in Fig. 3 that depicts examples of representative 
case studies.
Prediction of EPDS scores. Finally, we explored the possibility of a stratification of patients based on the 
results of psychosocial covariates alone without taking EPDS scores into account. To explore whether the regres-
sion model is powerful enough for prediction of EPDS scores as well (and not only for finding important covar-
iates of EPDS scores), we compared predictions derived from the four linear models (for AN and PP EPDS, 
average and difference EPDS) with predictions from a state-of-the-art machine learning prediction algorithm, 
extreme gradient boosting (xgboost). Details about this approach can be found in the supplementary material. 
Table 8 shows the result of a ten-fold cross validation (repeated 10 times) of the correlation of predicted scores 
with the measured scores. Interestingly, the linear models perform comparably (or even slightly better) than the 
state-of-the-art machine learning prediction algorithm, which depends very little on any statistical assumptions. 
This indicates that a simple linear model is able to capture most of the signal in the data that is suitable for predic-
tion. Prediction accuracy is highest for antenatal EPDS score, lower for the postpartum score, and in between for 
the APA score. The available covariates are better suited to predict depression before than after birth. It seems par-
ticularly difficult to predict the DPA score, i.e. the change in EPDS score from before to after delivery. However, 
compare the correlation of 0.19 of predicted postpartum EPDS scores with actual ones using only psychosocial 
covariates with the correlation of 0.50 of predicting them from prenatal EPDS scores. It is obvious that prenatal 
EPDS scores are still much better predictors of postpartum EPDS scores than generic psychosocial covariates.
Another way to assess prediction accuracy from a more practical perspective is to inspect PPV and NPV when 
turning predicted scores into predictions of depressive symptoms at an EPDS cut-off ≥10 (or ≥0 for the DPA 
Covariate Coefficient p-value
Social status - unemployed/student −2.664 0.040
Past history depression - yes 2.036 0.003
Past history of anxiety - yes −2.565 <0.001
Table 6. Significant covariates of a linear model for the difference of antenatal to postpartum (DPA) EPDS 
scores. The full model is provided in Suppl. Table 7.
Covariate Coefficient p-value
Social status - routine/semi-routine/HW 0.890 0.027
BMI ≥30 - yes −0.198 0.023
Alcohol pre-pregnancy - yes 0.764 0.039
Past history of PPD - yes 1.737 0.021
Past history depression - yes 2.027 0.001
Family history of PPD - 1st degree relative 1.574 0.002
Gestation length/days −0.029 0.029
Table 7. Significant covariates of a linear model for average antenatal and postpartum (APA) EPDS scores. The 
full model is provided in Suppl. Table 7.
Elastic net Linear Xgboost
AN EPDS 0.25 (0.02) 0.27 (0.02) 0.24 (0.02)
PP EPDS 0.19 (0.02) 0.18 (0.02) 0.16 (0.02)
DPA EPDS 0.13 (0.03) 0.15 (0.03) 0.13 (0.02)
APA EPDS 0.21 (0.02) 0.22 (0.02) 0.22 (0.02)
Table 8. Ten-fold cross validated correlation of prediction of EPDS scores with original scores based on 
predictors using penalised linear regression (elastic net), linear regression (linear), and extreme gradient 
boosting (xgboost). In brackets the standard deviation based on 20 random iterations. AN = antenatal; 
PP = postpartum.
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score). In our analysis we defined the PPV as the percentage of women predicted to have more severe depressive 
symptoms, who actually exhibit EPDS scores ≥10, while the NPV is the percentage of women predicted to have 
minimal symptoms who actually have EPDS <10. The result is shown in Table 9 for the linear and the xgboost 
predictor (due to the penalisation the absolute score value of the elastic net regression is not representative). The 
comparatively high correlation for antenatal EPDS score of Table 8 translates into a PPV of around 45% and a 
NPV of about 85% for the linear model and the xgboost predictor. As expected from the weaker correlation, pre-
dictive performance for the other scores is less impressive.
Discussion
Previous studies21,24 have shown a clear correlation between antenatal and postpartum EPDS scores. Our AUC 
analysis (Fig. 1) and correlation analysis (Fig. 2) show that the same relationship can be found in our data set. 
Going beyond previous studies we set out to analyse the contribution of psycho-socio-demographic covariates 
to antenatal, postnatal, and perinatal EPDS scores. The limited correlation of 0.50 between antenatal and post-
natal EPDS scores and the extreme differences between these two scores for some patients also raised the ques-
tion whether there are psychosocial factors contributing to this difference as illustrated in Fig. 3. A first analysis 
focused on EPDS scores dichotomised using a cut-off value (Table 3). A second analysis used the original EPDS 
scores for increased power (Tables 4–7). Both analyses resulted in qualitatively similar conclusions about the 
contributions of various psychosocial covariates. Finally, we explored how far psychosocial factors alone could be 
used in a clinical setting to predict EPDS scores (Tables 8 and 9).
Our statistical analysis used different types of regression and machine learning methods. Initially we dichoto-
mised EPDS scores to define a binary outcome of depressive symptoms in order to obtain estimates of effects 
and their significance that are more robust to potential misspecifications of the regression models. This approach 
is also more likely to be relevant for routine healthcare risk assessment approaches designed around the use of 
cut-offs; this was followed by development of regression models for the raw EPDS scores in order to increase 
exploratory power and to detect more subtle effects of covariates without the constraint of cut-offs. Finally we 
evaluated the predictive performance of the regression models in comparison to a state-of-the-art machine learn-
ing prediction method. This complementary but distinct statistical analysis identified a similar set of covariates.
By using EPDS to assess within-person patterns of change of depressive symptoms severity at two distinct time 
points antenatally (T1) and postpartum (T2) and using a single score cut-off (≥10) we identified three subgroups 
according to onset and duration or remission of symptoms. An antenatal vs postpartum EPDS score correlation 
of 0.5002 demonstrates that although there is a clear association, there is also a clear deviation of antenatal EPDS 
score from postpartum EPDS supporting the hypothesis of a multifactorial aetiology19.
Our analysis identified a ‘past history of anxiety or depression’ and ‘socioeconomic deprivation’ as some of 
the most important risk factors for perinatal depression, in agreement with many previous studies7,25,26. A past or 
family history of depression is a key risk factor for PPD, the average EPDS score between antenatal and postpar-
tum periods, as well as for bigger shifts between postpartum and antenatal EPDS scores. In fact, large prospective 
population-based studies suggest that the risk of PPD is more than 20 times higher for women with a history 
of depression compared to women without27. This may represent the most important factor to consider when 
developing a screening program. This finding is in agreement with recent sibling-twins studies that estimate the 
heritability of PND around 44–54%28. Interestingly, one-third of the genetic contribution appears to be unique to 
PND and not shared with non-perinatal depression, suggesting only partially overlapping genetic etiologies for 
perinatal and general nonperinatal depression.
Overall, these findings fit well with the conceptual framework describing stress vulnerability and depression 
in women5. Previous history of relevant illness might contribute to individual chronic and acute burdens and 
accumulation of life stressors that prevent effective adjustment of regulatory mechanisms. Previous studies that 
employed structural equation modelling to integrate variables such as stressful life events, social support, person-
ality traits, anxiety, coping strategies with postpartum depressive symptoms in a conceptual model of vulnera-
bility to PPD, suggest that women with specific personality traits are more sensitive to the depressogenic effects 
of adversity and stress events29. Similarly, socioeconomic deprivation is another factor clearly linked to stress 
vulnerability, as observed in low-income populations that exhibit higher levels of stress and impaired coping and 
depression. Therefore, our findings support and expand the biopsychosocial model of perinatal depression as pro-
posed by Leigh and Milgrom8; a modified version of the model incorporating our findings is presented in Fig. 4.
The complex interplay of stress vulnerability factors, precipitating factors associated with adjustment in preg-
nancy and antenatal stressors, personal resources and coping behaviours and predisposing factors result in a 
heterogeneous presentation of perinatal depression with affected women experience distinct patterns of onset 
of symptoms, severity, duration and recurrence. In general, as Tables 4 and 8 show, antenatal EPDS scores are 
better explained by socioeconomic and lifestyle factors (correlation 0.27). These covariates reflect a general level 
PPV/NPV Linear % Xgboost %
AN EPDS 43(8)/86(0.1) 47(5)/86(0.1)
PP EPDS 32(7)/81(0.1) 37(6)/81 (0.1)
DPA 61(1)/50(2) 61(1)/48(2)
APA 38(7)/88(0.1) 36(5)/88(0.1)
Table 9. Ten-fold cross validated positive predictive value (PPV) and negative predictive value (NPV) for 
prediction of depression based on predictors using linear regression (linear), and extreme gradient boosting 
(xgboost). In brackets the standard deviation based on 20 random iterations. AN = antenatal; PP = postpartum.
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of worry and anxiety, lack of support, harmful lifestyle habits such as excessive alcohol consumption and smoking 
coupled with lower social status and young age of the pregnant mother.
The protective effect of a higher social status demonstrated in this study points to the benefits of prioritising 
the most disadvantaged women. Some of these covariates also predict that depressive symptoms might ease after 
delivery (negative coefficients in Table 6). On the other hand, postpartum depressive symptoms are less reliably 
predicted by the available covariates (correlation 0.18) and are mostly associated with a previous history or a fam-
ily history of depression and PPD (Table 5). A similarly reduced predictive power of demographic and psychoso-
cial risk factors for PPD compared to AND has been previously reported5. These findings suggest a diminished 
contribution from environmental factors and hint at additional biological-genetic components for PPD.
As Table 9 shows, covariates that are routinely collected from women during antenatal visits, can be used to 
provide a probability whether an antenatal or postpartum EPDS score ≥10 might be attained by the individ-
ual, and are therefore predictive of perinatal depression to some degree. However, the predictive values are still 
inadequate and identification of additional useful predictors is required (e.g childbirth experience and health of 
the newborn). As previously mentioned30, the exploration of a genetic component, as suggested by the strong 
contribution of covariates indicating a family history of perinatal depression (Tables 5 and 7), might lead to an 
improvement in prediction.
Previous studies21 suggested that despite acceptable overall discriminatory power, the EPDS has limited pre-
dictive accuracy for absolute PPD risk stratification, regardless of the cut-off value used or the trimester of admin-
istration. This appears to be related to the presence of multiple risk factors that are postpartum-specific and 
therefore cannot be included in antenatal screening instruments31. To address this, one approach could combine 
screening for specific psychosocial risk factors alongside EPDS administration. For example, addition of prior 
history of depression and low partner support to antenatal EPDS seems to yield a more accurate overall predic-
tion of PPD32.
Limitations. A number of study limitations should be considered in the interpretation of these results. Care 
should be taken when comparing to other populations, since a high majority of our study population were White 
British and women were generally well educated and identified as ‘supported’. Depressive symptomatology was 
assessed through the use of a self-report screening instrument rather than clinical assessment, although the EPDS 
has been reported to have high sensitivity in a large number of studies both in the antenatal period and post-
partum33. A number of the variables used were binary (yes/no), limiting the conclusions we are able to make. 
Moreover, the interpretation of personal and family history of depression predicting PPD should be made with 
caution given that other important factors that contribute to the disease burden related to the childbirth experi-
ence34 and health of the newborn were not included in the analysis.
Finally, although our study design assessed depressive symptoms at two key time points during pregnancy and 
postpartum, we recognise that we did not capture the full temporal spectrum of symptoms onset or duration; for 
example women who experience transient symptoms during the first trimester or beyond 3 months postpartum 
since there was no follow-up post- 6–10 weeks postpartum, and therefore onset of depressive symptoms after the 
study period will not have been included in the analysis. The lack of multiple sampling points also did not allow 
application of modelling tools for identifying multiple un-observed sub-populations, describing longitudinal 
change within each sub-population, and examining differences in change among sub-populations. Such growth 
models typically require at least three repeated measures per individual35. This will be addressed in future studies.
Conclusions. This study provides novel evidence for distinct profiles of psycho-socio-demographic charac-
teristics associated with within-person heterogeneity of perinatal depressive symptoms severity, timing of onset 
Figure 4. A modified version of the Leigh and Milgrom8 biopsychosocial model of perinatal depression, 
incorporating findings from our study.
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and remission. Our results identified key predisposing factors that affect individual’s chronic/acute burden and 
stress vulnerability and influence depressive risk trajectories during pregnancy and postpartum. This suggests 
that as women move from the antenatal to the postpartum period, sociodemographic and lifestyle risk factors 
appear to play a smaller role in risk, and a personal and family history of depression and PPD become increasingly 
important. Inclusion of covariates, shown to be most predictive of perinatal depression as demonstrated in this 
study, in a predictive screening system could prioritise resources such as specialist assessment for women most 
at-risk. It should be emphasised that the covariates and models presented in this study only capture a small, albeit 
significant, amount of the variability observed in EPDS scores. Further studies, particularly including biological 
and genetic markers are needed in order to develop an effective screening strategy.
Methods
Recruitment, Study Design and Data Collection. Pregnant women were prospectively recruited during 
routine antenatal visits at the South Warwickshire Foundation NHS Trust, as part of the NIHR CRN Portfolio 
Study ‘Biomarkers of Perinatal depression. Ethical approval for this study was obtained from the National 
Research Ethics Service, UK Health Research Authority. All research was performed in accordance with relevant 
guidelines/regulations and informed consent was obtained from all participants.
Participants were asked to complete the EPDS, a 10 item self-report questionnaire. A detailed description of 
the study protocol is presented in the Supplementary methods. The antenatal EPDS assessment was carried out 
between 24–29 weeks gestation (T1) at a hospital visit. All participants were contacted following delivery of their 
baby and asked to complete a second EPDS at 6–10 weeks postpartum (T2) via post or telephone. Since there is 
no concensus agreement on the most appropriate assessment time, T1 was chosen to study depressive symptoms 
during the transition period between 2nd and 3rd trimester where women experience most uncomfortable phys-
ical symptoms, such as tiredness, difficulty eating or sleeping and also associated with most dramatic changes 
in hormonal milieu, especially placental hormones that control stress responses and may trigger rapid mood 
changes. This is also the period where most women have routine antenatal assessments, therefore translation of 
this research protocol in clinical practice will not impact on resources allocation in the current healthcare model. 
Most cases of PPD arise in the 1 to 6 months following childbirth. Generally, it is most common for postpartum 
depression begin sometime within the first 3 months postpartum therefore T2 was designed to capture the major-
ity of the women who will go to develop PPD36,37.
We used a score ≥10 as ‘screening positive’ for both minor and major depressive symptoms (‘high risk’ group). 
In addition, in some analyses we have interrogated groups with a higher cut-off score ≥13, which is recom-
mended to screen for MDD.
The EPDS was used here in a pre- and post-measures design. For the first stage of the analysis the cut-off score 
was used to classify patients as high vs low risk for depression during pregnancy or postpartum. This also allowed 
us to characterise distribution of scores and subgroup patients according to temporal patterns and possible recur-
rence of depressive symptomatology. For the next stage of the analysis, the EPDS was considered as a continuous 
scale in order not to constrain the EPDS data to dichotomous groups – this enabled analysis of the relationship 
between the data collected from the questionnaire variables and EPDS score. Rather than splitting women into 
high vs low risk groups, for this part of the analysis we instead interrogated the data to investigate which factors 
contribute higher scores on the EPDS.
Data was collected from the Health, Social and Family Health and Lifestyle Update forms completed at routine 
antenatal visits as part of normal procedures. A detailed description of the extracted variables is presented in the 
Supplementary Methods and are displayed in Suppl. Table 1. All questions from the Health, Social and Family 
forms and Lifestyle Updates are shown in Suppl. Table 1.
This study presents paired observational data from participants that completed the protocol resulting in 960 
complete observations (n = 480).
Statistical analysis. The aim of statistical analysis had three parts: (i) the investigation of distinct patterns 
of onset and persistence of PND symptoms from antenatal to the postnatal period; (ii) an exploration of the 
potential for covariate data gathered routinely from women during hospital visits to predict EPDS scores: (iii) to 
test the degree to which severity of antenatal and postpartum depression as well as the change in severity across 
the two periods was associated with distinct covariates risk profiles. Details of the statistical analysis approach is 
presented in the Supplementary Methods.
Ethics approval. The study protocol was approved by the NIHR Clinical Research Network as a Portfolio 
study (Study IRAS ID: 21234). The current study protocol REC reference is 09/H1203/69 and was approved on 
the 14-July 2014.
Data availability. The datasets analysed during the current study are available from the corresponding 
author on reasonable request.
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